Abreu, Maria T.

STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD

Turner, D., Ricciuto, A., Lewis, A., D’Amico, F., Dhaliwal, J., Griffiths, A. M., Bettenworth, D., Sandborn, W. J., Sands, B. E., Reinisch, W., et al. (2021) · Gastroenterology

Inflammatory Bowel DiseaseOcular Diseases and Behçet’s Syndrome

Cited by 2,911

A genomic mutational constraint map using variation in 76,156 human genomes

Chen, S., Francioli, L. C., Goodrich, J. K., Collins, R. L., Kanai, M., Wang, Q., Alföldi, J., Watts, N. A., Vittal, C., Gauthier, L. D., et al. (2024) · Nature

Genomics and Rare DiseasesGenetic Associations and Epidemiology

Cited by 1,727

Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function

Abreu, M. T. (2010) · Nature Reviews Immunology

Immune Response and InflammationGut microbiota and health

Cited by 1,288

Antibiotic therapy in inflammatory bowel disease: A systematic review and meta-analysis

Khan, K. J., Ullman, T. A., Ford, A. C., Abreu, M. T., Abadir, A., Marshall, J. K., Talley, N. J., & Moayyedi, P. (2011) · American Journal of Gastroenterology

Inflammatory Bowel DiseaseGut microbiota and health

Cited by 569

Human Intestinal Epithelial Cells Are Broadly Unresponsive to Toll-Like Receptor 2-Dependent Bacterial Ligands: Implications for Host-Microbial Interactions in the Gut

Melmed, G., Thomas, L. S., Lee, N., Tesfay, S. Y., Lukasek, K., Michelsen, K. S., Zhou, Y., Hu, B., Arditi, M., & Abreu, M. T. (2003) · The Journal of Immunology

Immune Response and InflammationGut microbiota and health

Cited by 431

Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease

Abreu, M. T., Taylor, K. D., Lin, Y.-C., Hang, T., Gaiennie, J., Landers, C. J., Vasiliauskas, E. A., Kam, L. Y., Rojany, M., Papadakis, K. A., et al. (2002) · Gastroenterology

Inflammatory Bowel DiseaseAutoimmune and Inflammatory Disorders

Cited by 428

Exercise Attenuates PCB-Induced Changes in the Mouse Gut Microbiome

Choi, J. J., Eum, S. Y., Rampersaud, E., Daunert, S., Abreu, M. T., & Toborek, M. (2013) · Environmental Health Perspectives

Gut microbiota and healthToxic Organic Pollutants Impact

Cited by 298

Dietary guidance from the international organization for the study of inflammatory bowel diseases

Levine, A., Rhodes, J. M., Lindsay, J. O., Abreu, M. T., Kamm, M. A., Gibson, P. R., Gasche, C., Silverberg, M. S., Mahadevan, U., Boneh, R. S., et al. (2020) · Clinical Gastroenterology and Hepatology

Inflammatory Bowel DiseaseNutritional Studies and Diet

Cited by 297

The incidence and risk factors for developing depression after being diagnosed with inflammatory bowel disease: a cohort study

Panara, A. J., Yarur, A. J., Rieders, B., Proksell, S., Deshpande, A. R., Abreu, M. T., & Sussman, D. A. (2014) · Alimentary Pharmacology & Therapeutics

Inflammatory Bowel DiseaseTryptophan and brain disorders

Cited by 168

A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis

Ungaro, R., Fukata, M., Hsu, D., Hernandez, Y., Breglio, K., Chen, A., Xu, R., Sotolongo, J., Espana, C., Zaias, J., et al. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology

Inflammatory Bowel DiseaseImmune Response and Inflammation

Cited by 159

Intestinal epithelial Toll-Like receptor 4 signaling affects epithelial function and colonic microbiota and promotes a risk for transmissible colitis

Dheer, R., Santaolalla, R., Davies, J. M., Lang, J. K., Phillips, M. C., Pastorini, C., Vazquez-Pertejo, M. T., & Abreu, M. T. (2016) · Infection and Immunity

Immune Response and InflammationGut microbiota and health

Cited by 144

The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease

Lopetuso, L. R., Deleu, S., Godny, L., Petito, V., Puca, P., Facciotti, F., Sokol, H., Ianiro, G., Masucci, L., Abreu, M., et al. (2023) · Gut

Inflammatory Bowel DiseaseGut microbiota and health

Cited by 129

An international consensus to standardize integration of histopathology in ulcerative colitis clinical trials

Ma, C., Sedano, R., Almradi, A., Vande Casteele, N., Parker, C. E., Guizzetti, L., Schaeffer, D. F., Riddell, R. H., Pai, R. K., Battat, R., et al. (2021) · Gastroenterology

Inflammatory Bowel DiseaseMicroscopic Colitis

Cited by 105

The Xenobiotic Transporter Mdr1 Enforces T Cell Homeostasis in the Presence of Intestinal Bile Acids

Cao, W., Kayama, H., Chen, M. L., Delmas, A., Sun, A., Kim, S. Y., Rangarajan, E. S., McKevitt, K., Beck, A. P., Jackson, C. B., et al. (2017) · Immunity

Drug Transport and Resistance MechanismsInflammatory Bowel Disease

Cited by 102

Colorectal Cancer Immunotherapy: State of the Art and Future Directions

Cornista, A. M., Giolito, M. V., Baker, K., Hazime, H., Dufait, I., Datta, J., Khumukcham, S. S., De Ridder, M., Roper, J., Abreu, M. T., et al. (2023) · Gastro Hep Advances

Cancer Immunotherapy and BiomarkersColorectal Cancer Treatments and Studies

Cited by 39